Site-specific conjugation and labelling of prostate antibody 7E11C5.3 (CYT-351) with technetium-99m
- 10 June 1997
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 24 (6) , 651-654
- https://doi.org/10.1007/bf00841403
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Imaging prostate cancer with technetium-99m-7E11-C5.3 (CYT-351).1997
- Prostatic radioimmunoscintigraphy: preliminary results using technetium-labelled monoclonal antibody, CYT-351British Journal of Urology, 1996
- Can a cysteine challenge assay predict the in vivo behavior of 99mTc-labeled antibodies?Nuclear Medicine and Biology, 1994
- The influence of periodate oxidation on monoclonal antibody avidity and immunoreactivityJournal of Immunological Methods, 1991
- REDUCTION-MEDIATED TC-99M LABELING OF MONOCLONAL-ANTIBODIES1990
- Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.1987
- Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluations.Proceedings of the National Academy of Sciences, 1986